HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xeroderma pigmentosum variant: 5 years of tumour suppression by etretinate.

AuthorsJ Berth-Jones, J Cole, A R Lehmann, C F Arlett, R A Graham-Brown
JournalJournal of the Royal Society of Medicine (J R Soc Med) Vol. 86 Issue 6 Pg. 355-6 (Jun 1993) ISSN: 0141-0768 [Print] England
PMID8315632 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Etretinate
Topics
  • Aged
  • DNA Repair
  • Etretinate (therapeutic use)
  • Facial Neoplasms (prevention & control)
  • Hand
  • Humans
  • Male
  • Skin Neoplasms (drug therapy, genetics, prevention & control)
  • Xeroderma Pigmentosum (drug therapy, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: